UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. )*
SKINVISIBLE, INC.
-------------------------------------------------
(NAME OF ISSUER)
COMMON STOCK, $0.001 PAR VALUE
-------------------------------------------------
(TITLE OF CLASS OF SECURITIES)
830703 10 4
-------------------------------------------------
(CUSIP NUMBER)
FEBRUARY 27, 2006
----------------------------------------------------------------
(DATE OF EVENT WHICH REQUIRES FILING OF THIS STATEMENT)
CHECK THE APPROPRIATE BOX TO DESIGNATE THE RULE PURSUANT TO WHICH THIS SCHEDULE
IS FILED:
[ ] Rule 13d-1(b)
[ X ] Rule 13d-1(c)
[ ] Rule 13d-1(d)
* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 ("Act") or otherwise subject to the liabilities of that section of
the Act but shall be subject to all other provisions of the Act (however, see
the Notes).
________________________________________________________________________________
1. NAME OF REPORTING PERSON.
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (entities only)
EMD CHEMICALS INC.
________________________________________________________________________________
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a) [_]
(b) [_]
________________________________________________________________________________
3. SEC USE ONLY
________________________________________________________________________________
4. CITIZENSHIP OR PLACE OF ORGANIZATION
NEW YORK
________________________________________________________________________________
Number of 5. SOLE VOTING POWER
0
Shares
_________________________________________________________________
Beneficially 6. SHARED VOTING POWER
5,817,525*
Owned By
_________________________________________________________________
Each 7. SOLE DISPOSITIVE POWER
0
Reporting
_________________________________________________________________
Person 8. SHARED DISPOSITIVE POWER
5,817,525*
With
________________________________________________________________________________
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,817,525*
________________________________________________________________________________
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(See Instructions) [_]
________________________________________________________________________________
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
9.1%
________________________________________________________________________________
12. TYPE OF REPORTING PERSON (See Instructions)
CO
________________________________________________________________________________
* Consists of an option to purchase 5,817,525 shares of Skinvisible, Inc. Common
Stock, exercisable at any time until December 31, 2006.
________________________________________________________________________________
1. NAME OF REPORTING PERSON.
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (entities only)
EMD CHEMICALS US HOLDINGS INC.
________________________________________________________________________________
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a) [_]
(b) [_]
________________________________________________________________________________
3. SEC USE ONLY
________________________________________________________________________________
4. CITIZENSHIP OR PLACE OF ORGANIZATION
DELAWARE
________________________________________________________________________________
Number of 5. SOLE VOTING POWER
0
Shares
_________________________________________________________________
Beneficially 6. SHARED VOTING POWER
5,817,525*
Owned By
_________________________________________________________________
Each 7. SOLE DISPOSITIVE POWER
0
Reporting
_________________________________________________________________
Person 8. SHARED DISPOSITIVE POWER
5,817,525*
With
________________________________________________________________________________
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,817,525*
________________________________________________________________________________
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(See Instructions) [_]
________________________________________________________________________________
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
9.1%
________________________________________________________________________________
12. TYPE OF REPORTING PERSON (See Instructions)
HC
________________________________________________________________________________
* Consists of an option to purchase 5,817,525 shares of Skinvisible, Inc. Common
Stock, exercisable at any time until December 31, 2006.
________________________________________________________________________________
1. NAME OF REPORTING PERSON.
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (entities only)
CHEMITRA GMBH
________________________________________________________________________________
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a) [_]
(b) [_]
________________________________________________________________________________
3. SEC USE ONLY
________________________________________________________________________________
4. CITIZENSHIP OR PLACE OF ORGANIZATION
THE FEDERAL REPUBLIC OF GERMANY
________________________________________________________________________________
Number of 5. SOLE VOTING POWER
0
Shares
_________________________________________________________________
Beneficially 6. SHARED VOTING POWER
5,817,525*
Owned By
_________________________________________________________________
Each 7. SOLE DISPOSITIVE POWER
0
Reporting
_________________________________________________________________
Person 8. SHARED DISPOSITIVE POWER
5,817,525*
With
________________________________________________________________________________
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,817,525*
________________________________________________________________________________
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(See Instructions) [_]
________________________________________________________________________________
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
9.1%
________________________________________________________________________________
12. TYPE OF REPORTING PERSON (See Instructions)
OO (SEE ITEM 2)
________________________________________________________________________________
* Consists of an option to purchase 5,817,525 shares of Skinvisible, Inc. Common
Stock, exercisable at any time until December 31, 2006.
________________________________________________________________________________
1. NAME OF REPORTING PERSON.
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (entities only)
MERCK KGAA
________________________________________________________________________________
2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a) [_]
(b) [_]
________________________________________________________________________________
3. SEC USE ONLY
________________________________________________________________________________
4. CITIZENSHIP OR PLACE OF ORGANIZATION
THE FEDERAL REPUBLIC OF GERMANY
________________________________________________________________________________
Number of 5. SOLE VOTING POWER
0
Shares
_________________________________________________________________
Beneficially 6. SHARED VOTING POWER
5,817,525*
Owned By
_________________________________________________________________
Each 7. SOLE DISPOSITIVE POWER
0
Reporting
_________________________________________________________________
Person 8. SHARED DISPOSITIVE POWER
5,817,525*
With
________________________________________________________________________________
9. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
5,817,525*
________________________________________________________________________________
10. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
(See Instructions) [_]
________________________________________________________________________________
11. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
9.1%
________________________________________________________________________________
12. TYPE OF REPORTING PERSON (See Instructions)
OO (SEE ITEM 2)
________________________________________________________________________________
* Consists of an option to purchase 5,817,525 shares of Skinvisible, Inc. Common
Stock, exercisable at any time until December 31, 2006.
ITEM 1. ISSUER INFORMATION
(a) Name of Issuer:
Skinvisible, Inc.
(b) Address of Issuer's Principal Executive Offices:
Skinvisible, Inc.
6320 S. Sandhill Rd., Suite 10
Las Vegas, Nevada 89120
ITEM 2. REPORTING PERSONS INFORMATION
Item 2(a) Item 2(b) Item 2(c)
--------- --------- ---------
Name of Persons Filing Address Citizenship
EMD Chemicals Inc. 480 S. Democrat Road Incorporated in New York
Gibbstown, New Jersey 08027
EMD Chemicals US Holdings Inc. 103 Foulk Road, Suite 205-11 Incorporated in Delaware
Wilmington, DE 19803
Chemitra GmbH Frankfurter Str. 250 A company organized under
64293 Darmstadt, Germany the laws of the Federal
Republic of Germany
Merck KGaA Frankfurter Str. 250 A company organized under
64293 Darmstadt, Germany the laws of the Federal
Republic of Germany
Item 2(d) Title of Class of Securities:
Common Stock, par value $0.001
Item 2(e) CUSIP Number:
---------
830703 10 4
ITEM 3. IF THIS STATEMENT IS FILED PURSUANT TO RULE 13D-1(B), OR 13D-2(B), CHECK
WHETHER THE PERSON FILING IS A:
[ ] Broker or Dealer registered under Section 15 of the Act.
[ ] Bank as defined in Section 3(a)(6) of the Act.
[ ] Insurance Company as defined in Section 3(a)(19) of the Act.
[ ] Investment company registered under Section 8 of the
Investment Company Act of 1940.
[ ] An investment adviser in accordance with Rule
13d-1(b)(1)(ii)(E);
[ ] An employee benefit plan or endowment fund in accordance
with Rule 13d-1(b)(1)(ii)(F);
[ ] A parent holding company or control person in accordance
with Rule 13d-1(b)(1)(ii)(G);
[ ] A savings associations as defined in Section 3(b) of the
Federal Deposit Insurance Act (12 U.S.C. 1813);
[ ] A church plan that is excluded from the definition of an
investment company under section 3(c)(14) of the Investment
Company Act of 1940;
[ ] Group, in accordance with Rule 13d-1(b)(1)(ii)(J).
None of the above.
ITEM 4. OWNERSHIP
(a) Amount Beneficially Owned: As of February 27, 2006, EMD Chemicals Inc. ("EMD") was
granted an option to purchase 5,817,525 shares of Common
Stock of Skinvisible, Inc., exercisable at any time until
December 31, 2006. EMD Chemicals US Holdings Inc., a
wholly-owned subsidiary of Chemitra GmbH, is the holding
company of EMD. Merck KGaA is the ultimate parent entity
of each of Chemitra GmbH, EMD Chemicals US Holdings Inc.
and EMD. By virtue of their relationship as affiliated
companies, each of these entities may be deemed to share
voting power and the power to direct the disposition of
the 5,817,525 shares of Common Stock which EMD is deemed
to beneficially own.
(b) Percent of Class:
EMD Chemicals Inc. 9.1 %**
EMD Chemicals US Holdings Inc. 9.1 %**
Chemitra GmbH 9.1 %**
Merck KGaA 9.1 %**
** See Item 4(a) above for description of beneficial ownership.
The foregoing percentages are calculated based on 63,992,773 shares of
Common Stock deemed to be outstanding, which assumes the exercise of the option
to purchase 5,817,525 shares of Common Stock in addition to 58,175,248 shares of
Common Stock reported to be outstanding as of October 27, 2005 in the Quarterly
Report on Form 10-QSB of Skinvisible, Inc. for the quarter ended September 30,
2005.
(c) Number of shares as to which such person has:
(i) sole power to vote or to direct the vote:
EMD Chemicals Inc. 0 shares**
EMD Chemicals US Holdings Inc. 0 shares**
Chemitra GmbH 0 shares**
Merck KGaA 0 shares**
(ii) shared power to vote or to direct the vote:
EMD Chemicals Inc. 5,817,525 shares**
EMD Chemicals US Holdings Inc. 5,817,525 shares**
Chemitra GmbH 5,817,525 shares**
Merck KGaA 5,817,525 shares**
(iii) sole power to dispose or to direct the disposition of:
EMD Chemicals Inc. 0 shares**
EMD Chemicals US Holdings Inc. 0 shares**
Chemitra GmbH 0 shares**
Merck KGaA 0 shares**
(iv) shared power to dispose or to direct the disposition of:
EMD Chemicals Inc. 5,817,525 shares**
EMD Chemicals US Holdings Inc. 5,817,525 shares**
Chemitra GmbH 5,817,525 shares**
Merck KGaA 5,817,525 shares**
** See Item 4(a) above for description of beneficial ownership.
ITEM 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
Not applicable.
ITEM 6. OWNERSHIP OF MORE THAT FIVE PERCENT ON BEHALF OF ANOTHER
PERSON
Not applicable.
ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH
ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING
COMPANY
See Item 4(a) above.
ITEM 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP
The reporting persons are filing this Schedule as a "group"
pursuant to Rules 13d-1(k)(1) and 13d-1(c) of the Securities Exchange Act of
1934. As required, attached is an exhibit listing of the members of the group.
The reporting persons are not, however, part of a "group" as defined in Rule
13d-1(b)(ii)(J).
ITEM 9. NOTICE OF DISSOLUTION OF GROUP
Not applicable.
ITEM 10. CERTIFICATION
By signing below we each certify that, to the best of our
knowledge and belief, the securities referred to above were not acquired and are
not held for the purpose of or with the effect of changing or influencing the
control of the issuer of the securities and were not acquired and are not held
in connection with or as a participant in any transaction having that purpose or
effect.
SIGNATURES
After reasonable inquiry and to the best of our knowledge and belief,
we certify that the information set forth in this statement is true, complete
and correct.
EMD CHEMICALS INC.
By: /s/ Douglas Brown
-------------------------------------
Name: Douglas Brown
-------------------------------------
Title: President and Chief Executive Officer
-------------------------------------
EMD CHEMICALS US HOLDINGS INC.
By: /s/ Jens Rohne
-------------------------------------
Name: Jens Rohne
-------------------------------------
Title: President
-------------------------------------
CHEMITRA GMBH
By: /s/ Ulrich Fogel
-------------------------------------
Name: Ulrich Fogel
-------------------------------------
Title: Director
-------------------------------------
MERCK KGAA
By: /s/ Dr. G. Falcke /s/ Thomas Zens
-------------------------------------
Name: Dr. G. Falcke Thomas Zens
-------------------------------------
Title: Vice President Senior Manager
-------------------------------------
EXHIBIT A
IDENTITY OF GROUP MEMBERS PURSUANT TO ITEM 8
The members of the group are:
--------------------------------------- ----------------------------------
Name Address
--------------------------------------- ----------------------------------
EMD Chemicals Inc. 480 S. Democrat Road
Gibbstown, New Jersey 08027
--------------------------------------- ----------------------------------
EMD Chemicals US Holdings Inc. 103 Foulk Road, Suite 205-11
Wilmington DE, 19803
--------------------------------------- ----------------------------------
Chemitra GmbH Frankfurter Str. 250
64293 Darmstadt, Germany
--------------------------------------- ----------------------------------
Merck KGaA Frankfurter Str. 250
64293 Darmstadt, Germany
--------------------------------------- ----------------------------------
EXHIBIT B
JOINT FILING AGREEMENT
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934,
the undersigned hereby agree to the joint filing on behalf of each of them of a
Schedule 13G (including any and all amendments thereto) with respect to the
Common Stock of Skinvisible, Inc., and further agree that this Agreement shall
be included as an Exhibit to such filings.
The undersigned further agree that each party hereto is responsible for
timely filing of such Schedule 13G and any amendments thereto, and for the
completeness and accuracy of the information concerning such party contained
therein, provided that neither party is responsible for the completeness or
accuracy of the information concerning the other party, unless such party knows
or has reason to believe that such information is inaccurate.
IN WITNESS WHEREOF, the undersigned have caused this Agreement to be
executed this 9th day of March, 2006.
EMD CHEMICALS INC.
By: /s/ Douglas Brown
-------------------------------------
Name: Douglas Brown
-------------------------------------
Title: President and Chief Executive Officer
-------------------------------------
EMD CHEMICALS US HOLDINGS INC.
By: /s/ Jens Rohne
-------------------------------------
Name: Jens Rohne
-------------------------------------
Title: President
-------------------------------------
CHEMITRA GMBH
By: /s/ Ulrich Fogel
-------------------------------------
Name: Ulrich Fogel
-------------------------------------
Title: Director
-------------------------------------
MERCK KGAA
By: /s/ Dr. G. Falcke /s/ Thomas Zens
-------------------------------------
Name: Dr. G. Falcke Thomas Zens
-------------------------------------
Title: Vice President Senior Manager
-------------------------------------